J&J nabs label expansion for Stelara in pediatric psoriatic arthritis

Nearly a decade after J&J’s Stelara was approved to treat adults with psoriatic arthritis, the pharma giant is expanding the label to include the small percentage of children who suffer from the autoimmune disease.